CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Ideal Option Releases 2025 Patient Outcomes Annual Report, Highlighting Life-Saving Treatment Amid Montana's Shifting Fentanyl Crisis

Positive
AI Analysis

Summary

Ideal Option released its 2025 Patient Outcomes Annual Report showing 97% opioid abstinence rates among long-term patients, with data indicating statewide overdose deaths beginning to decline in Montana. The report highlights the effectiveness of outpatient medication-assisted treatment for opioid and stimulant addiction.

Importance:2/10
Sentiment:
0.70
medication-assisted treatmentopioid addictionpatient outcomesoutpatient treatmentabstinence rates
Related Companies

Read the original article

Published by PR Newswire Pharma on September 14, 2026 12:00 PM

Read Original